General Information of the Compound
| Compound ID |
CP0519809
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-4-[(2S)-2-(anilinomethyl)pyrrolidine-1-carbonyl]-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-10-yl]propanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C41H57N9O9S2
|
||||||||||||||||||
| Molecular Weight |
884.095
|
||||||||||||||||||
| Canonical SMILES |
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1CNc1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C41H57N9O9S2/c1-3-24(2)36-40(58)46-29(15-16-33(42)52)37(55)47-31(21-34(43)53)38(56)48-32(41(59)50-18-7-10-27(50)22-44-26-8-5-4-6-9-26)23-61-60-19-17-35(54)45-30(39(57)49-36)20-25-11-13-28(51)14-12-25/h4-6,8-9,11-14,24,27,29-32,36,44,51H,3,7,10,15-23H2,1-2H3,(H2,42,52)(H2,43,53)(H,45,54)(H,46,58)(H,47,55)(H,48,56)(H,49,57)/t24-,27-,29-,30-,31-,32-,36-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MTTJJKKZLLZUPK-UOVRCBJPSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound